Antithrombotic Effects of Recombinant Hirudin in Experimental Angioplasty and Intravascular Thrombolysis

Summary

The effect of recombinant desulphatohirudin CGP 39393 (rH) on arterial thrombus formation and especially on thrombotic reocclusion after experimental angioplasty as well as after thrombolysis was investigated in rabbits. In the femoral artery thrombi were induced after endothelial damage of the vessel wall by a balloon catheter and following stasis. After removing the thrombus by angioplasty or after lysing it by streptokinase reocclusion of the artery was observed within a relatively short period of time. Subcutaneous injection of rH reduced the incidence of both primary thrombus formation and reocclusion in dependence on the dose administered. After a dose of rH of 2 mg/kg s.c. arterial thrombus formation was completely prevented and after administering 4 mg/kg s.c. thrombotic reocclusion did also not occur. Comparative studies with heparin showed that similar antithrombotic effects were only achieved at doses of 12 mg heparin/kg s.c. The results obtained suggest a clear potential of rH for prevention of thrombotic reocclusion in clinical states.

Keywords

Recombinant hirudin - Experimental angioplasty - Thrombolysis - Reocclusion

• References

• 1 Markwardt F. Hirudin as an inhibitor of thrombin. In: Methods in Enzymology Perlman GE, Lorand L. (eds). Academic Press; New York: 1970. Vol 19 924-932
• 2 Markwardt F. Pharmacology of hirudin: One hundred years after the first report of the anticoagulant agent in medicinal leeches. Biomed Biochim Acta 1985; 44: 1007-1013
• 3 Markwardt F. The comeback of hirudin - an old-established anticoagulant agent. Folia Haematol 1988; 115: 10-23
• 4 Bucha E, Nowak G, Markwardt F. Prevention of experimental coronary thrombosis by hirudin. Folia Haematol 1988; 115: 64-69
• 5 Hauptmann J, Brüggener E, Markwardt F. Effect of heparin, hirudin, and a synthetic thrombin inhibitor on antithrombin III in thrombin-induced disseminated intravascular coagulation in rats. Haemostasis 1987; 17: 321-328
• 6 Kaiser B, Markwardt F. Antithrombotic and haemorrhagic effects of the naturally occurring thrombin inhibitor hirudin. Folia Haematol 1988; 115: 41-46
• 7 Markwardt F, Hauptmann J, Nowak G, Kleßen C, Walsmann P. Pharmacological studies on the antithrombotic action of hirudin in experimental animals. Thromb Haemostas 1982; 47: 226-229
• 8 Markwardt F, Nowak G, Hoffmann J. Comparative studies on thrombin inhibitors in experimental microthrombosis. Thromb Haemostas 1983; 49: 235-237
• 9 Nowak G, Markwardt F. Influence of hirudin on endotoxin-induced disseminated intravascular coagulation (DIC) in weaned pigs. Exp Pathol 1980; 18: 438-443
• 10 Markwardt F, Fink E, Kaiser B, Klöcking H-P, Nowak G, Richter M, Stürzebecher J. Pharmacological survey of recombinant hirudin. Pharmazie 1988; 43: 202-207
• 11 Markwardt F, Kaiser B, Nowak G. Studies on antithrombotic effects of recombinant hirudin. Thromb Res 1989; 54: 377-388
• 12 Talbot MD, Ambler J, Butler KD, Findlay VS, Mitchell KA, Peters RF, Tweed MF, Wallis RB. Recombinant desulphatohirudin (CGP 39393) anticoagulant and antithrombotic properties in vivo. Thromb Haemostas 1989; 61: 77-80
• 13 Walsmann P, Kaiser B. Biochemical and pharmacological properties of recombinant hirudin. Drugs of Today 1989; 25: 473-85
• 14 Grossenbacher H, Anden JA L, Bill K, Liersch M, Maerki W, Maschler R. Isolation and characterization of recombinant desul-fatohirudin from yeast, a highly selective thrombin inhibitor. Thromb Res 1987; (Suppl. 07) 34
• 15 Meyhack B, Heim J, Rink H, Zimmermann W, Maerki W. Desul-fatohirudin, a specific thrombin inhibitor: expression and secretion in yeast. Thromb Res 1987; (Suppl. 07) 33
• 16 Dodt J, Seemüller U, Maschler R, Fritz H. The complete covalent structure of hirudin. Localization of the disulfide bonds. Biol Chem Hoppe-Seyler 1985 366. 379-385
• 17 Klöcking H-P. Zur Pharmakologie des Streptokinasepraparates Awelysin®. Folia Haematol 1976; 103: 445-455
• 18 Markwardt F, Klöcking H-P, Sedlarik K, Perlewitz J, Drawert J, Hoffmann J. Tierexperimentelle Untersuchungen zur thromboly-tischen Wirkung von Streptokinase. Acta Biol Med Germ 1976; 35: 193-203
• 19 Chesebro JH, Lam JY T, Badimon L, Fuster V. Restenosis after arterial angioplasty: A hemorrheologic response to injury. Am J Cardiol 1987; 60: 10B-16B
• 20 Harker LA. Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty. Am J Cardiol 1987; 60: 20B-28B
• 21 Heras M, Chesebro JH, Penny WJ, Bailey KR, Lam JY T, Holmes DR, Reeder GS, Badimon L, Fuster V. Importance of adequate heparin dosage in arterial angioplasty in a porcine model. Circulation 1988; 78: 654-660
• 22 Sugrue DD, Holmes Jr DR, Smith HC, Reeder GS, Lane GE, Vlietstra RE, Bresnahan JF, Hammes LN, Piehler JM. Coronary artery thrombus as a risk factor for acute vessel occlusion during percutaneous transluminal coronary angioplasty: improving results. Br Heart J 1986; 56: 62-66
• 23 Eisenberg PR, Sherman LA, Jaffe AS. Paradoxic elevation of fibrinopeptide A after streptokinase: Evidence for continued thrombosis despite intense fibrinolysis. J Am Coll Cardiol 1987; 10: 527-530
• 24 Owen J, Friedman KD, Grossmann BA, Wilkins C, Berke AD, Powers ER. Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activity. Blood 1988; 72: 616-620
• 25 Seitz R, Blanke H, Prätorius G, Strauer BE, Egbring R. Increased thrombin activity during thrombolysis. Thromb Haemostas 1988; 59: 541-542
• 26 Liu CY, Nossel HL, Kaplan KL. The binding of thrombin by fibrin. J Biol Chem 1979; 254: 10421-10425
• 27 Erhardt L, Emanuelsson H, Hartford M, Johnsson H, Strandberg L-E. Coronary thrombolysis. Principles and practice. Acta Med Scand 1988 224. 413-424
• 28 Gabliani G, Deligonul U, Kern MJ, Vandormael M. Acute coronary occlusion occurring after successful percutaneous transluminal coronary angioplasty: Temporal relationship to discontinuation of anticoagulation. Am Heart J 1988; 116: 696-700
• 29 Steele PM, Chesebro JH, Stanson AW, Holmes Jr DR, Dewanjee MK, Badimon L, Fuster V. Balloon angioplasty: Natural history of the pathophysiological response to injury in a pig model. Circ Res 1985; 57: 105-12